big mover upSIONmassive
Sionna Therapeutics, Inc. (SION) Surges 5.0% on Heavy Volume
Sionna Therapeutics, Inc. (NASDAQ:SION) surged 5.0% in today's trading, closing at $6.24.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Sionna Therapeutics, Inc. (NASDAQ:SION) surged 5.0% in today's trading, closing at $6.24.
Read moreZoom Communications, Inc. (NASDAQ:ZM) is scheduled to report its Q2 earnings results on August 20, 2026 after market close.
Read moreDirexion Daily FTSE China Bull 3X Shares (AMEX:YINN) surged 5.0% in today's trading, closing at $29.97.
Read moreNovozymes A/S (OTC:NVZMY) is scheduled to report its Q2 earnings results on August 20, 2026 after market close.
Read moreJones Lang LaSalle Incorporated (NYSE:JLL) surged 5.0% in today's trading, closing at $389.75.
Read moreSWMR (NASDAQ:SWMR) is scheduled to report its Q2 earnings results on August 20, 2026 after market close.
Read moreClearPoint Neuro, Inc. (NASDAQ:CLPT) surged 5.0% in today's trading, closing at $15.95.
Read moreUpstart Holdings, Inc. (NASDAQ:UPST) surged 5.0% in today's trading, closing at $30.57.
Read moreEvaxion Biotech A/S (NASDAQ:EVAX) is scheduled to report its Q2 earnings results on August 20, 2026 after market close.
Read moreQiagen N.V. (NYSE:QGEN) surged 5.0% in today's trading, closing at $44.45.
Read moreNeogen Corporation (NASDAQ:NEOG) surged 5.0% in today's trading, closing at $12.15.
Read moreFST Corp. (NASDAQ:KBSX) is scheduled to report its Q2 earnings results on August 20, 2026 after market close.
Read moreDUKR (NASDAQ:DUKR) is scheduled to report its Q2 earnings results on August 20, 2026 after market close.
Read moreNeedham reiterated its Buy rating on Streamex Corp. (NASDAQ:STEX) on August 18, 2026.
Read moreRosenblatt reiterated its Buy rating on SK Growth Opportunities Corporation (NASDAQ:SKGRU) on August 18, 2026.
Read moreBaird analysts downgraded Ramaco Resources, Inc. (NASDAQ:METC) from Outperform to Neutral on August 18, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on Ramaco Resources, Inc. (NASDAQ:METC) on August 18, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) on August 18, 2026.
Read moreCitigroup reiterated its Buy rating on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) on August 18, 2026.
Read moreHC Wainwright & Co. reiterated its Neutral rating on BioMarin Pharmaceutical Inc.
Read more